retatrutide phase Retatrutide: FDA approval time, trial results & weight loss Eli Lilly infiltrates anti-obesity market

When will Retatrutide be FDA-approved

Retatrutide is great for weight loss

Weight Loss Distribution The results weren't just impressive on averagethey were consistent across the patient population: Weight Loss Thresholds Achieved (12mg dose): 5% weight loss: 94.6% of participants 10% weight loss: 91.3% of participants 15% weight loss: 83.2% of participants 20% weight loss: 73.4% of participants 25% weight loss: 58.6% of participants For comparison, FDA approval for obesity medications typically requires that at least 35% of patients achieve 5% weight loss

Nevertheless, more rigorous scientific studies would be needed to get more exact numbers